<SEC-DOCUMENT>0001683168-26-001789.txt : 20260313
<SEC-HEADER>0001683168-26-001789.hdr.sgml : 20260313
<ACCEPTANCE-DATETIME>20260313200758
ACCESSION NUMBER:		0001683168-26-001789
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260311
FILED AS OF DATE:		20260313
DATE AS OF CHANGE:		20260313

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Mears Robert J
		CENTRAL INDEX KEY:			0001680617
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37850
		FILM NUMBER:		26754056

	MAIL ADDRESS:	
		STREET 1:		750 UNIVERSITY AVENUE, SUITE 280
		CITY:			LOS GATOS
		STATE:			CA
		ZIP:			95032

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Atomera Inc
		CENTRAL INDEX KEY:			0001420520
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		750 UNIVERSITY AVENUE
		STREET 2:		SUITE 280
		CITY:			LOS GATOS
		STATE:			CA
		ZIP:			95032
		BUSINESS PHONE:		408-442-5248

	MAIL ADDRESS:	
		STREET 1:		750 UNIVERSITY AVENUE
		STREET 2:		SUITE 280
		CITY:			LOS GATOS
		STATE:			CA
		ZIP:			95032

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MEARS TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20071206
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2026-03-11</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001420520</issuerCik>
        <issuerName>Atomera Inc</issuerName>
        <issuerTradingSymbol>ATOM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001680617</rptOwnerCik>
            <rptOwnerName>Mears Robert J</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ATOMERA, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>750 UNIVERSITY AVENUE, SUITE 280</rptOwnerStreet2>
            <rptOwnerCity>LOS GATOS</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>95032</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Chief Technology Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>0</aff10b5One>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Performance Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>5.10</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-03-11</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>5</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value>E</value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>32868</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2036-03-11</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>32868</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>32868</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
        <derivativeTransaction>
            <securityTitle>
                <value>Performance Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>5.10</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-03-11</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>5</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value>E</value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>32868</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2036-03-11</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>32868</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>32868</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
        <derivativeTransaction>
            <securityTitle>
                <value>Performance Stock Option (right to buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>5.10</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2026-03-11</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>5</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness>
                <value>E</value>
            </transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>65736</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.00</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2036-03-11</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>65736</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>65736</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $7.50. In the event the $7.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.</footnote>
        <footnote id="F2">Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $12.50. In the event the $12.50 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.</footnote>
        <footnote id="F3">Performance-based grant with vesting based on both Company stock price performance and time. The first 25% vests on March 1, 2027, with the balance vesting in 12 equal quarterly installments thereafter, but only if the average volume-weighted price over any 30 consecutive trading days during the five-year period from the date of grant equals or exceeds $20.00. In the event the $20.00 price threshold is not met within five years from the date of grant, no options will vest and all options will terminate at the end of the five year period.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>By: Mindi Zimmer, as Attorney-in-Fact For: Robert J. Mears</signatureName>
        <signatureDate>2026-03-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
